Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 865 (LINC00865) is a long non-coding RNA (lncRNA) gene located on chromosome 10q23.31, spanning approximately 400,000 base pairs[1][3][5][7]. LINC00865 does not encode a protein but may play a regulatory role in gene expression and chromatin architecture, similar to other lncRNAs, and is primarily classified as an RNA gene of the lncRNA class[3][5][7]. LINC00865 has been weakly associated with glioma susceptibility, though there is little direct evidence linking it to disease-specific mechanisms or to use as a biomarker or therapeutic target[7][9]. No drugs or specific modulators have been reported to target LINC00865[7][9]. Its broader family, lncRNAs, are recognized to regulate gene expression at multiple levels, including chromatin modification, transcription, and post-transcriptional regulation[10]. Currently, LINC00865 itself is not considered a clinically actionable or therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 865 (LINC00865).